Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propofol-remifentanil Versus Dexmedetomidine in Awake Craniotomy: an Intraoperative Neurophysiological Evaluation

NCT05103735 is registered in ClinicalTrials.gov with Azienda Sanitaria-Universitaria Integrata di Udine as lead sponsor.

NCT NCT05103735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05103735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propofol-remifentanil Versus Dexmedetomidine in Awake Craniotomy: an Intraoperative Neurophysiological Evaluation
Lead sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
Phase
Observational
Overall status
Completed
Start date
September 15, 2021
Completion date
October 11, 2021
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral tumor, craniotomy, dexmedetomidine, neurophysiology, propofol, remifentanil, seizures